Stocks in Spotlight Within Pharma Sector in India
The Indian pharmaceutical sector offers a great potential for investments as the pharma market is projected for a steady growth. The sector saw a 7.5% YoY revenue growth in February 2025, primarily driven by price growth and new product launches even though volume growth has remained sluggish. The sector is now projected to grow at an incredible 8-9% annual rate in FY26.
Within the pharma sector, the cardiac therapies lead with a 10.8 % growth in Moving Annual Total (MAT), which tracks the 12-month rolling sales of all pharmaceutical products. The other sectors like gastroenterology, neurology and Central Nervous System, and dermatology also showed strong growth.
While the Indian pharmaceutical sector is expanding its capabilities in APIs and biotechnology, it has grown at twice the global average rate of 8 % CAGR. India is also the world’s largest supplier of generic medicines. With these strong fundamentals, the Indian pharmaceuticals sector offers good investment opportunities. Here are the top pharmaceutical stocks based on their 5-year CAGR.
Top Pharmaceutical Stocks Based on 5Y CAGR
Laurus Labs Ltd
- Market Cap (₹ Crore): 30,144.21
- 5Y CAGR (%): 47.41
Caplin Point Laboratories Ltd
- Market Cap (₹ Crore): 14,500.37
- 5Y CAGR (%): 45.93
J B Chemicals and Pharmaceuticals Ltd
- Market Cap (₹ Crore): 24,764.86
- 5Y CAGR (%): 42.02
Glenmark Pharmaceuticals Ltd
- Market Cap (₹ Crore): 39,593.82
- 5Y CAGR (%): 39.46
Sun Pharmaceutical Industries Ltd
- Market Cap (₹ Crore): 3,86,652.83
- 5Y CAGR (%): 32.58
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.